Sudeep Pharma 2026 Report: Pharma Excipients and Battery Growth
Sudeep Pharma, listed on NSE in November 2025, reports 49% revenue growth to 172 crore in Q3 FY26 and enters battery materials via iron phosphate for EVs.
Articles tagged with "sudeep-pharma"
Sudeep Pharma, listed on NSE in November 2025, reports 49% revenue growth to 172 crore in Q3 FY26 and enters battery materials via iron phosphate for EVs.